Pharmacogenomics in psychiatry: From therapeutic drug monitoring to genomic medicine

S. Crettol, J. De Leon, C. Hiemke, C. B. Eap

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Psychiatry is increasingly combining new pharmacogenomic findings with therapeutic drug monitoring (TDM) to improve the safety and efficacy of pharmacotherapy. However, a distinction should be made between "nice to know" and "need to know" pharmacogenomic data because many results are statistically significant in meta-analyses but are not clinically relevant due to their low effect sizes. Some examples will illustrate this integration.

Original languageEnglish
Pages (from-to)254-257
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume95
Issue number3
DOIs
StatePublished - Mar 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Pharmacogenomics in psychiatry: From therapeutic drug monitoring to genomic medicine'. Together they form a unique fingerprint.

Cite this